Finance

Lists
COR:NYSE
Cencora Inc
339,09 US$
-0,63%
(-2,16) 1D
339,00 US$
-0,03% (-0,090)
After hours
Closed: 20 ნოე, 16:00:05 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COR...
Open
344,31 US$
High
348,57 US$
Low
337,86 US$
Mkt. cap
14,99 მლრდ.
Avg. vol.
1,36 მლნ.
Volume
1,23 მლნ.
52-wk high
377,54 US$
52-wk low
244,82 US$
Beta
0,58
Shares outstanding
190,83 მლნ.
No. of employees
49 ათ.
Open
344,31 US$
High
348,57 US$
Low
337,86 US$
Mkt. cap
14,99 მლრდ.
Avg. vol.
1,36 მლნ.
Volume
1,23 მლნ.
52-wk high
377,54 US$
52-wk low
244,82 US$
Beta
0,58
Shares outstanding
190,83 მლნ.
No. of employees
49 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
9 საათის წინ
Cencora stock: Wells Fargo lifts target to 400 dollars
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc
CEOრობერ მაუჩ
Employees49 ათ.
Founded1871
Headquarters-
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 11 analysts giving stock ratings to COR in the past 3 months
Strong buy
Buy
9
Hold
2
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for COR in the last 3 months.
Highest
Current 339,09 US$
415,00 US$ (+22,39%)
Average
387,73 US$ (+14,34%)
Lowest
330,00 US$ (-2,68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Erin Wright
Morgan Stanley
Buy
Reiterated
377,00 US$
+11,2%
11/19/2026
Glen Santangelo
Barclays
Buy
Reiterated
415,00 US$
+22,4%
11/17/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
400,00 US$
+18%
11/17/2026
Allen Lutz
Bank of America Securities
Hold
Maintained
360,00 US$
+6,2%
11/10/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
413,00 US$
+21,8%
11/10/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
405,00 US$
+19,4%
11/05/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
380,00 US$
+12,1%
11/05/2026
Ryan Halsted
RBC Capital
Hold
Reiterated
330,00 US$
-2,7%
11/05/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
405,00 US$
+19,4%
11/05/2026
David Toung
Argus Research
Buy
Maintained
380,00 US$
+12,1%
10/20/2026
Kevin Caliendo
UBS
Buy
Maintained
400,00 US$
+18%
10/16/2026
Charles Rhyee
TD Cowen
Buy
Maintained
400,00 US$
+18%
08/09/2026
Daniel Grosslight
Citi
Buy
Maintained
370,00 US$
+9,1%
08/06/2026
Ryan Daniels
William Blair
Hold
Reiterated
-
-
08/05/2026
Max Smock
William Blair
Hold
Maintained
-
-
05/22/2026
Last report
4 ნოე. 2026
Fiscal period
Q4 2026
4,66 US$ / 4,57 US$
+1,88%beat
Revenue / Est. (USD)
88,35 მლრდ. / 87,91 მლრდ.
+0,50%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
85,93 მლრდ.
78,36 მლრდ.
84,75 მლრდ.
88,35 მლრდ.
Cost of goods sold
82,87 მლრდ.
74,78 მლრდ.
81,15 მლრდ.
84,79 მლრდ.
Cost of revenue
82,87 მლრდ.
74,78 მლრდ.
81,15 მლრდ.
84,79 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,80 მლრდ.
1,98 მლრდ.
2,13 მლრდ.
2,17 მლრდ.
Operating expense
2,06 მლრდ.
2,23 მლრდ.
2,40 მლრდ.
2,44 მლრდ.
Total operating expenses
84,93 მლრდ.
77,01 მლრდ.
83,56 მლრდ.
87,23 მლრდ.
Operating income
1,00 მლრდ.
1,34 მლრდ.
1,20 მლრდ.
1,12 მლრდ.
Other non operating income
10,10 მლნ.
-173,00 ათ.
16,88 მლნ.
16,69 მლნ.
EBT including unusual items
708,64 მლნ.
2,09 მლრდ.
996,39 მლნ.
787,21 მლნ.
EBT excluding unusual items
941,56 მლნ.
1,20 მლრდ.
1,08 მლრდ.
1,00 მლრდ.
Income tax expense
142,51 მლნ.
459,04 მლნ.
219,73 მლნ.
258,11 მლნ.
Effective tax rate
20,11%
21,98%
22,05%
32,79%
Other operating expenses
362,00 ათ.
595,00 ათ.
881,00 ათ.
-
Net income
559,65 მლნ.
1,64 მლრდ.
763,52 მლნ.
519,40 მლნ.
Net profit margin
0,65%
2,09%
0,90%
0,59%
Earnings per share
4,08
4,75
4,48
4,66
Interest and investment income
20,95 მლნ.
13,88 მლნ.
13,82 მლნ.
-
Interest expense
-93,36 მლნ.
-154,34 მლნ.
-154,52 მლნ.
-136,29 მლნ.
Net interest expenses
-72,41 მლნ.
-140,46 მლნ.
-140,70 მლნ.
-136,29 მლნ.
Depreciation and amortization charges
134,29 მლნ.
132,14 მლნ.
150,96 მლნ.
266,24 მლნ.
EBITDA
1,27 მლრდ.
1,60 მლრდ.
1,47 მლრდ.
1,37 მლრდ.
Gain or loss from assets sale
-35,82 მლნ.
-234,00 ათ.
-15,96 მლნ.
52,02 მლნ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები